Back to Search
CALEB MATTHEW UNGER MD
MD
Family Medicine Physician
NPI: 1891312674IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
58669(KY)11021347A(IN)
Education
OTHER
Class of 2019
Research & Publications (20)
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.
PMID 19404684·Support Care Cancer·2010
3-trial
INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model.
PMID 19148580·Invest New Drugs·2010
4-observational
Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells.
PMID 19556288·Hum Reprod·2009
7-preclinical
Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer.
PMID 19142174·Pancreas·2009
7-preclinical
Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.
PMID 19399788·Prostate·2009
7-preclinical
Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: a dose-dependent effect of osterix over-expression.
PMID 18932205·J Cell Physiol·2009
8-other
An in vitro ES cell imprinting model shows that imprinted expression of the Igf2r gene arises from an allele-specific expression bias.
PMID 19141673·Development·2009
7-preclinical
Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment.
PMID 18164554·Neuroscience·2008
7-preclinical
Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation.
PMID 18617691·Stem Cells·2008
7-preclinical
Derivation of human skin fibroblast lines for feeder cells of human embryonic stem cells.
PMID 18770630·Curr Protoc Stem Cell Biol·2008
8-other
A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.
PMID 17554540·Cancer Chemother Pharmacol·2008
7-preclinical
Good manufacturing practice and clinical-grade human embryonic stem cell lines.
PMID 18632697·Hum Mol Genet·2008
6-review
Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP).
PMID 17973264·Int J Cancer·2008
7-preclinical
Novel cryopreservation method for dissociated human embryonic stem cells in the presence of a ROCK inhibitor.
PMID 18716037·Hum Reprod·2008
8-other
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress.
PMID 17344052·Neurobiol Dis·2007
7-preclinical
Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study.
PMID 18063875·Onkologie·2007
3-trial
Determination of neomycin and bacitracin in human or rabbit serum by HPLC-MS/MS.
PMID 16971085·J Pharm Biomed Anal·2007
4-observational
Identification of molecular compounds critical to Alzheimer's-like plaque formation.
PMID 17492785·J Neurosci Res·2007
8-other
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors.
PMID 17634482·J Clin Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2401 TERRA CROSSING BLVD STE 101
LOUISVILLE, KY 40245 - Phone
- (502) 210-4600
Quick Facts
- NPI
- 1891312674
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile